Tobam Illumina, Inc. Transaction History

Tobam

$1.12 Billion
Q1 2024

A detailed history of Tobam transactions in Illumina, Inc. stock. As of the latest transaction made, Tobam holds 631 shares of ILMN stock, worth $66,431. This represents 0.01% of its overall portfolio holdings.

Number of Shares

631

Previous 382 65.18%

Holding current value

$66,431

Previous $53,000 64.15%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$127.73 - $147.2 $31,804 - $36,652	249 Added 65.18%	631 $87,000
Q4 2023 Jan 26, 2024	SELL	$92.79 - $142.53 $57,993 - $89,081	-625 Reduced 62.07%	382 $53,000
Q1 2023 May 03, 2023	BUY	$193.75 - $232.55 $28,093 - $33,719	145 Added 16.82%	1,007 $234,000
Q3 2022 Nov 02, 2022	SELL	$177.23 - $227.44 $29,420 - $37,755	-166 Reduced 16.15%	862 $164,000
Q2 2022 Aug 02, 2022	BUY	$181.58 - $368.0 $18,702 - $37,904	103 Added 11.14%	1,028 $190,000

Q1 2022 Apr 25, 2022	BUY	$303.87 - $423.8 $129,448 - $180,538	426 Added 85.37%	925 $323,000
Q3 2020 Nov 12, 2020	BUY	$268.51 - $400.74 $133,986 - $199,969	499 New	499 $154,000
Q2 2018 Aug 03, 2018	SELL	$228.17 - $292.07 $3.58 Million - $4.59 Million	-15,709 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$209.54 - $253.91 $13.1 Million - $15.8 Million	-62,332 Reduced 79.87%	15,709 $3.71 Million
Q4 2017 Feb 14, 2018	SELL	$202.23 - $230.03 $21.7 Million - $24.7 Million	-107,195 Reduced 57.87%	78,041 $17.1 Million
Q3 2017 Nov 14, 2017	SELL	$172.3 - $213.93 $4.92 Million - $6.1 Million	-28,533 Reduced 13.35%	185,236 $36.9 Million
Q2 2017 Aug 08, 2017	BUY	N/A	213,769	213,769 $37.1 Million

Others Institutions Holding ILMN

# of Institutions

877

Shares Held

139M

Call Options Held

1.09M

Put Options Held

1.91M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $16.6B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account